ArticleKorean circulation journal2019

Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway.

Inho Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.